[144]
It was not possible for Dr. Hayakawa's research team at Daiichi to directly resolve ofloxacin to isolate therefrom the S(-) enantiomer and the R(+) enantiomer:
[Diagram omitted - see printed version]
It was necessary for Dr. Hayakawa and his co-inventors to develop synthetic techniques for producing the S(-) enantiomer of ofloxacin - i.e., Processes A, B and C. (Klibanov Affidavit at para. 72, AR, v. 12, Tab 17, p. 3419; Klibanov Affidavit, Exhibit S, v. 13, Tab 18(S), p. 4013.)
[Diagram omitted - see printed version]